Whitepaper

Across all BioPharma companies, irrespective of their sizes, have reached a content breaking point. Traditional methods of document creation and publishing no longer serve the best interests of the corporation, the content creators, or the end consumer. There is tremendous momentum behind efforts to modernize the way we create, store, manage, publish, and update content.

Everyone knows that copying and pasting (and tweaking) content from document to document is time-consuming and fraught with risk. To mitigate that risk, many companies are embracing the possibilities of structured content (irrespective of what interface they use, MS Word or Web-based). Many Companies have made the decision to move to a structured content authoring environment. However, for structured content to deliver on its promises, the content must be standardized and also integrate well with MS Word (as it’s still the primary go-to authoring tool for many).